Biomedical Materials Market 2028 By Product, Application, End user and Geography | The Insight Partners

report image

Biomedical Materials Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Metallic Biomaterial, Ceramic Biomaterial, Polymeric Biomaterial, Natural Biomaterial); Application (Cardiovascular, Orthopedic, Ophthalmology, Dental, Plastic Surgery, Wound Healing, Neurology, Others); End user (Healthcare facilities, Diagnostic centres, Tissue engineering, Others) and Geography

Report Code: TIPRE00013707 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming


Biomedical materials are used for medical purposes by replacing, augmenting, or accelerating the natural function of the body. These materials are either natural or synthesized in the laboratory, making use of a number of chemical approaches utilizing metallic components, polymers, ceramics, or composite materials. Various biomedical materials are available in the market targeting every body part. These materials include silicone hydrogels, biostable polyurethanes, polymer stabilizing technology, resorbable materials, hydrophilic and non-hydrophilic biofouling coatings, and UHMWPE (Ultra High Molecular Weight Poly-Ethylene) fibers. Growth in the prevalence of diseases and a boost in government incentives has led to a rise in demand for biomedical materials in the market.


The biomedical materials market is on a high rise and is expected to reach USD 348.4 billion by 2028 by a CAGR of 15.9% over the forecast period. Easy availability of natural and synthetic degradable polymers and their wide demand in surgical sutures and implants has led this to be the largest revenue share of the polymers product segment. The high demand for surgical procedures over the years, the betterment of the geriatric population, and focus on the target diseases are some of the essential factors that are boosting the sales of biomaterials in the healthcare delivery systems worldwide.


The "Biomedical Material Market Analysis to 2028" is a specialized and in-depth study of the medical devices in the healthcare industry with a particular focus on the global market trend analysis. This report aims to provide an overview of the biomedical material market with detailed market segmentation by product type, application type, and end-user type. The Biomedical material market is expected to witness a high rise during the forecast period. The report provides key statistics on the market status of the leading players in the biomedical material market and offers key trends and opportunities in the market.


The biomedical material market is segmented on the basis of product type, application type, and end-user type. Based on product type, the market is segmented as Metallic biomaterial, Ceramic biomaterial, Polymeric biomaterial, and Natural biomaterial. Based on the application type, the market is categorized as Cardiovascular, Orthopedic, Ophthalmology, Dental, Plastic surgery, Wound healing, Neurology, and others. Based on end-user type, the market is segmented as Healthcare facilities, Diagnostic centers, Tissue engineering, and others.


The report provides a detailed outline of the industry, including both qualitative and quantitative information. It provides a sketch and forecast of the Biomedical material market based on various segments. It also consists of market size and forecast estimates from the year 2020 to2028with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America. The biomedical materials market by each region is later sub-segmented into respective countries and segments. The report consists of the analysis and forecast of 18 countries globally, along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the biomedical material market from both demand and supply side. Further, it assesses market dynamics affecting the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. The report also provides detailed PEST analysis for all five regions, namely; North America, Europe, APAC, MEA, and South & Central America, after evaluating political, economic, social, and technological factors affecting the Biomedical material market in these regions.

Get more information on this report :


The report covers key developments in the biomedical material market as organic and inorganic growth strategies. Various firms are focusing on organic growth strategies like product launches, product approvals, and others, such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions and partnerships & collaborations. These activities have cleared the way for the expansion of business and customer base of market players. The market players from the biomedical material market are anticipated to have lucrative growth opportunities in the future with the rising demand for biomaterials in the global market. Mentioned below is the list of few companies engaged in the biomedical material market.
The report also contains the profiles of key players in the biomedical material market, along with their SWOT analysis and market strategies. Additionally, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last three years, key development in the past five years.

  •  DSM
  •  Corbion
  •  CRS Holdings Inc.
  •  Evonik Industries AG
  •  Covestro AG(Subsidiary of Bayer AG)
  •  Invibio Ltd.(Subsidiary of Victrex)
  •  F. Hoffmann-La Roche Ltd
  •  CAM Bioceramics B.V.
  •  Celanese Corporation
  •  Formosa Biomedical Technology Corp

The Insight Partner's dedicated research and analysis team comprises of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

1. DSM
2. Corbion
3. CRS Holdings Inc.
4. Evonik Industries AG
5. Covestro AG(Subsidiary of Bayer AG)
6. Invibio Ltd.(Subsidiary of Victrex)
7. F. Hoffmann-La Roche Ltd
8. CAM Bioceramics B.V.
9. Celanese Corporation
10. Formosa Biomedical Technology Corp
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount